The company has developed two unique supplement lines and is developing treatments for diseases. The new Cavit facility is significantly larger than the company’s previous space and accommodates our research and development, operations and marketing. The space has been designed to meet Cavit’s unique requirements for two separate facilities; one for the development of the supplement lines and the second for the development of cancer and viral infection treatments. The facility includes research labs, clinical testing labs, clean rooms, development labs, corporate offices and warehouse space.
Colm King, CEO of Cavit, said: “The company is experiencing the planned growth of our business strategy. Cavit’s space needs have grown with the development of our supplement lines and the ongoing development of treatments for diseases.”